Health TrialsbyHealthPanel

Feasibility Study to Actively Disseminate the Latin America and the Caribbean Code Against Cancer in Primary Healthcare Centers

ConditionsCancerLatin America and the Caribbean Code Against Cancer (LAC Code)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHospital Israelita Albert Einstein

About this trial

Phase II non-randomized four-arm study (before/after pragmatic trial) that will test 2 different implementation strategies either combined or separately for the dissemination of the Latin America and the Caribbean Code Against Cancer within four different primary healthcare units in Aparecida de Goiânia.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults (≥18 years old)

Registered at a participating primary healthcare center (UBS) in Aparecida de Goiânia

Healthcare professionals with at least three months of employment at a participating UBS

Ability to provide informed consent

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • WhatsApp-Based Cancer Prevention Messaging

    Behavioral

    Participants in this group will receive a structured series of WhatsApp messages containing evidence-based cancer prevention recommendations from the Latin America and Caribbean Code Against Cancer (LAC Code). Messages will be delivered over four weeks, 3 times a week, covering key topics such as smoking cessation, healthy diet, physical activity, and regular screening. Engagement metrics will be tracked to assess feasibility and adherence.

  • Online Cancer Prevention Workshop for Healthcare Professionals

    Behavioral

    Healthcare professionals assigned to this group will participate in an online workshop designed to improve their knowledge of the LAC Code and communication strategies for cancer prevention counseling. The workshop includes recorded lectures, interactive modules, and knowledge assessments. Completion rates and participant satisfaction will be measured.

  • Combined WhatsApp Messaging and Online Workshop

    Behavioral

    Participants in this group will receive both interventions: WhatsApp messages with cancer prevention recommendations and access to the online workshop. The intervention aims to assess whether a combined approach enhances adherence and impact. Engagement with both interventions will be monitored.

Treatment groups

1,200 Participants
are divided into 4 treatment groups
Group A: Control GroupNo intervention 0 interventions
Group B: G1: WhatsApp Messaging Intervention - General PopulationExperimental treatment 1 intervention
Group C: G2: Online Workshop for Healthcare Professionals (HCP)Experimental treatment 1 intervention
Group D: G3: Combined Intervention (WhatsApp + Workshop)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility of the WhatsApp-Based Intervention

Number of participants who report having read at least one WhatsApp message.

Time frame
Up to 2 weeks after WhatsApp intervention completion
2

Acceptability of the WhatsApp-Based Intervention

Mean acceptability score from participant survey (Likert scale 1-5) evaluating message usefulness and clarity.

Time frame
Up to 2 weeks after WhatsApp intervention completion
3

Appropriateness of the WhatsApp-Based Intervention

Proportion of participants who indicate willingness to receive similar messages in the future (Yes/No).

Time frame
Up to 2 weeks after WhatsApp intervention completion

Secondary outcomes

Other outcomes

1

Receipt of Cancer Prevention Counseling Among the General Population (KAS Questionnaire)

Proportion of general population participants reporting receipt of at least one type of cancer prevention counseling (e.g., smoking cessation, diet, physical activity) as assessed by the KAS questionnaire

Time frame
Baseline and final assessment (up to 2 weeks after intervention)
2

Intention to Provide Cancer Prevention Counseling Among Healthcare Professionals (KAP Questionnaire)

Proportion of healthcare professionals reporting intention to integrate cancer prevention counseling into clinical practice, assessed via the KAP questionnaire.

Time frame
Baseline, post-workshop (up to 2 weeks), and final assessment (up to 2 weeks after intervention)

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hospital Israelita Albert Einstein

Lead sponsor

International Agency for Research on Cancer

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: